August 16, 2024 11:17 AM EDTUpdated 01:41 PM
Deals
Outsourcing

Avan­tor sells off CRO for $650M to pri­vate eq­ui­ty firm

Katherine Lewin

News Reporter

Au­dax Pri­vate Eq­ui­ty is buy­ing Avan­tor’s CRO busi­ness for about $650 mil­lion.

The deal, an­nounced Fri­day, is for Avan­tor’s clin­i­cal ser­vices …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Bris­tol My­ers re­veals more job cuts in New Jer­sey

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Gilead buys ex­per­i­men­tal HIV vac­cines from a small Barcelona biotech

A service from the Financial Times